| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |